The situation of women in Science, Technology, Engineering, and Mathematics (STEM) in Kenya reflects a global trend of underrepresentation, often referred to as a "leaky pipeline," in which female ...
In this phase 2 study, researchers aimed to evaluate the effectiveness of tyrosine kinase inhibition in relapsed or refractory germ cell tumors. The clinical benefit rate with cabozantinib was 43.2%.
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial TF was detectable in 75.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results